AMRX
$19.84+2.48%
Amneal Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.09% of IWMNasdaq Composite · 0.01% of ONEQRussell 3000 · 0.004% of IWVUS Stock Market · 0.004% of VTI
AMRX financial statements
The full income statement, balance sheet, and cash-flow statement for Amneal Pharmaceuticals Inc. (AMRX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 309.5M2024-09 309.8M2024-12 310.0M2025-03 313.4M2025-06 314.1M2025-09 314.4M2025-12 314.6M2026-03 319.0M2026-06 319.4M+3.2% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.02B+8.0% | 2.79B+16.7% | 2.39B+8.2% | 2.21B+5.7% | 2.09B+5.1% | |
| 1.11B+9.1% | 1.02B+24.4% | 821M+4.6% | 785M+2.0% | 769M+22.4% | ||
| Cost of revenue | 1.91B+7.4% | 1.77B+12.7% | 1.57B+10.2% | 1.43B+7.8% | 1.32B-0.4% | |
| Research & development | 186M-2.4% | 191M+16.3% | 164M-16.2% | 196M-3.1% | 202M+12.2% | |
| Selling, general & administrative | 527M+10.6% | 476M+10.9% | 430M+7.5% | 400M+9.4% | 366M+11.9% | |
| Restructuring | 4.21M+78.7% | 2.35M+34.6% | 1.75M+23.1% | 1.42M-23.5% | 1.86M-22.6% | |
| Amortization of intangibles | 166M-4.2% | 174M+6.4% | 163M-5.2% | 172M-0.3% | 173M-1.3% | |
| Operating income | 394M+58.1% | 249M+22.0% | 204M+315.3% | -94.9M-162.2% | 153M+67.5% | |
| Other non-operating income | 16.5M+40.2% | 11.8M+42.9% | 8.24M-55.4% | 18.5M+20.4% | 15.3M+491.9% | |
| Pre-tax income | 139M+353.0% | -55.0M-36.6% | -40.3M+83.8% | -248M-891.1% | 31.4M+187.7% | |
| Income tax | 11.3M-40.2% | 18.9M+123.2% | 8.45M+26.9% | 6.66M-40.5% | 11.2M+110.7% | |
| 72.1M+161.6% | -117M-39.2% | -84.0M+69.0% | -271M-2155.6% | 13.2M-80.6% | ||
| Net income to non-controlling interest | 55.9M+29.9% | 43.0M+21.9% | 35.3M+128.2% | -125M-1412.0% | 9.55M+142.5% | |
| Net income to common | 72.1M+161.6% | -117M-39.2% | -84.0M+35.4% | -130M-1323.5% | 10.6M-88.3% | |
| $0.22+157.9% | -$0.38+20.8% | -$0.48+44.2% | -$0.86-1328.6% | $0.07-88.5% | ||
| EPS (basic) | $0.23+160.5% | -$0.38+20.8% | -$0.48+44.2% | -$0.86-1328.6% | $0.07-88.7% | |
| Weighted-avg shares (basic) | 313M+1.4% | 309M+75.4% | 176M+16.7% | 151M+1.4% | 149M+1.0% | |
| Weighted-avg shares (diluted) | 325M+5.1% | 309M+75.4% | 176M+16.7% | 151M-0.6% | 152M+2.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.91B+20.4% | 1.59B+15.2% | 1.38B-2.4% | 1.41B-7.1% | 1.52B-2.0% | ||
| Cash & equivalents | 282M+155.1% | 111M+20.8% | 91.5M+252.4% | 26.0M-89.5% | 248M-27.4% | |
| Accounts receivable | — | — | — | 742M+12.0% | 663M+3.7% | |
| Inventory | 606M-1.0% | 612M+5.3% | 581M+9.5% | 531M+8.4% | 489M-0.3% | |
| Prepaid expenses | 98.4M+21.9% | 80.7M-2.4% | 82.7M-20.2% | 104M-6.0% | 110M+50.0% | |
| 3.68B+5.1% | 3.50B+0.8% | 3.47B-8.6% | 3.80B-3.6% | 3.94B-1.7% | ||
| Property, plant & equipment | 443M+4.2% | 425M-5.1% | 448M-4.7% | 470M-8.6% | 514M+7.6% | |
| Operating lease right-of-use | 54.0M+27.6% | 42.4M-2.2% | 43.3M-22.9% | 56.1M-7.0% | 60.4M+2.8% | |
| Goodwill | 595M-0.3% | 597M-0.2% | 599M-0.0% | 599M+1.0% | 593M+13.4% | |
| Intangible assets | 563M-23.1% | 732M-17.7% | 890M-18.8% | 1.10B-6.1% | 1.17B-10.6% | |
| Other non-current assets | 57.8M-3.9% | 60.1M+8.3% | 55.5M-46.2% | 103M+400.7% | 20.6M-7.7% | |
| 882M-22.0% | 1.13B+33.4% | 847M+12.5% | 753M+11.2% | 677M+0.1% | ||
| Accounts payable | — | 259M+80.2% | 144M-13.5% | 166M+26.6% | 131M-14.4% | |
| Accrued liabilities | — | — | — | 538M+2.4% | 525M-14.1% | |
| Short-term & current debt | 6.76M-97.0% | 224M+557.0% | 34.1M+13.9% | 30.0M-2.1% | 30.6M-30.8% | |
| Long-term debt | 2.57B+18.7% | 2.16B-9.4% | 2.39B-7.9% | 2.59B-3.3% | 2.68B-2.0% | |
| Operating lease liability (total) | 58.8M+25.0% | 47.0M-3.8% | 48.9M-17.4% | 59.2M-7.5% | 64.0M+2.4% | |
| Finance lease liability (total) | 58.4M-2.9% | 60.1M-1.5% | 61.0M-5.0% | 64.3M+1.4% | 63.4M-3.2% | |
| Other non-current liabilities | — | — | — | 87.5M+124.8% | 38.9M-53.3% | |
| Total non-current liabilities | 2.79B+15.5% | 2.42B-5.8% | 2.56B-9.6% | 2.84B-1.4% | 2.88B-3.2% | |
| -70.8M+35.2% | -109M-652.4% | 19.8M-93.4% | 298M-17.2% | 360M+18.8% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 572M+2.1% | 560M+3.9% | 539M-22.0% | 692M+5.1% | 658M+4.8% | |
| Retained earnings | -535M+11.9% | -607M-23.8% | -490M-20.7% | -406M-47.1% | -276M+3.7% | |
| Accumulated other comprehensive income | -111M-69.0% | -65.5M-102.5% | -32.3M-425.5% | 9.94M+140.0% | -24.8M+39.9% | |
| Non-controlling interest | -535K-118.4% | -245K-206.5% | 230K+100.2% | -114M-1825.3% | 6.63M-84.1% | |
| Total equity incl. non-controlling | -71.3M+34.9% | -110M-647.3% | 20.0M-89.1% | 184M-49.9% | 367M+6.4% | |
| Total liabilities & equity | 3.68B+5.1% | 3.50B+0.8% | 3.47B-8.6% | 3.80B-3.6% | 3.94B-1.7% | |
| Common shares outstanding | 315M+1.5% | 310M+1.1% | 307M | — | 603M+0.6% | |
| Shares outstanding (cover) | 315M+1.5% | 310M+1.0% | 307M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 340M+15.2% | 295M-14.6% | 346M+430.8% | 65.1M-73.1% | 242M-36.2% | ||
| Depreciation & amortization | 224M-5.3% | 236M+3.0% | 229M-4.5% | 240M+2.9% | 233M-0.8% | |
| Intangible amortization | 166M-4.2% | 174M+6.4% | 163M-5.2% | 172M-0.3% | 173M-1.3% | |
| Share-based compensation | 32.0M+15.1% | 27.8M+3.5% | 26.8M-15.8% | 31.8M+12.1% | 28.4M+36.9% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in receivables | 121M-25.9% | 163M+228.8% | -126M-258.4% | 79.7M+237.5% | 23.6M+240.7% | |
| Change in inventory | 87.0M-33.3% | 131M+3.4% | 126M+23.2% | 102M+108.9% | 49.0M-56.9% | |
| -112M-78.2% | -63.0M+9.0% | -69.2M+60.3% | -174M+10.2% | -194M+38.8% | ||
| Capital expenditure | 70.1M+34.9% | 51.9M+20.1% | 43.2M-6.9% | 46.4M-2.8% | 47.7M-15.4% | |
| Free cash flow | 270M+11.0% | 243M-19.6% | 302M+1517.5% | 18.7M-90.4% | 194M-39.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00-100.0% | 84.7M-42.2% | 147M-41.7% | |
| -31.5M+85.1% | -212M+0.4% | -213M-99.4% | -107M+22.8% | -138M-204.8% | ||
| Long-term debt issued | 2.69B | 0.00-100.0% | 218M | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | -1.68M-68.2% | -999K-1636.9% | 65.0K+101.1% | -5.68M-5671.6% | 102K-90.2% | |
| Net change in cash | 195M+907.2% | 19.3M-69.8% | 63.9M+128.8% | -222M-145.1% | -90.4M-146.5% | |
| Interest paid | 198M-24.9% | 264M+36.7% | 193M+35.1% | 143M+17.2% | 122M-6.5% | |
| Income taxes paid | 21.3M+40.1% | 15.2M+509.8% | 2.50M-80.3% | 12.6M+181.3% | -15.6M-115.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 3.96B+61.5% | 2.45B-34.0% | 3.72B+515.9% | 604M-79.1% | 2.89B+5.4% | |
| P/E | 55.0× | — | 1414.6× | — | 219.5×+442.9% | |
| P/S | 1.3×+49.5% | 0.9×-43.6% | 1.6×+452.2% | 0.3×-79.5% | 1.4×+0.3% | |
| P/B | — | — | 11.2×+453.8% | 2.0×-74.7% | 8.0×-11.3% | |
| P/FCF | 14.7×+45.5% | 10.1×-61.6% | 26.3×+331.4% | 6.1×-59.1% | 14.9×+75.2% | |
| Earnings yield | 1.8% | — | 0.07% | — | 0.46%-81.6% | |
| FCF yield | 6.8%-31.3% | 9.9%+160.2% | 3.8%-76.8% | 16.4%+144.4% | 6.7%-42.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AMRX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AMRX filings on SEC EDGAR → Not investment advice.